Universitätsspital Basel

Hospital


Location: Basel, Switzerland (CH) CH

ISNI: -

ROR: https://ror.org/04k51q396

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Atopy patch testing with aeroallergens in a large clinical population of dermatitis patients in Germany and Switzerland, 2000-2015: a retrospective multicentre study (2020) Dickel H, Kuhlmann L, Bauer A, Bircher AJ, Breuer K, Fuchs T, Grabbe J, et al. Journal article Novel biomarker of sphericity and cylindricity indices in volume-rendering optical coherence tomography angiography in normal and diabetic eyes: a preliminary study (2020) Maloca PM, Spaide RF, de Carvalho ER, Studer HP, W Hasler P, Scholl HP, Heeren TF, et al. Journal article Randomized Clinical Trial Comparing a Rivaroxaban-Based Strategy With an Antiplatelet-Based Strategy for the Prevention of Subclinical Leaflet Thrombosis in Transcatheter Aortic Valves (GALILEO-4D) (2019) De Backer O, Dangas G, Jilaihawi H, Leipsic J, Terkelsen CJ, Makkar R, Kini AS, et al. Conference contribution Der sichere Lappen – Präoperatives Gefäß-Mapping und intraoperative Perfusionsmessung zur Reduktion der lappenbedingten Morbidität (2019) Schmauss D, Schmauss D, Beier JP, Eisenhardt SU, Horch RE, Momeni A, Rab M, et al. Journal article High-Risk Additional Chromosomal Abnormalities in CML Herald Death By Blast Crisis Already at Low Blast Levels (2019) Hehlmann R, Voskanyan A, Lauseker M, Pfirrmann M, Kalmanti L, Rinaldetti S, Kohlbrenner K, et al. Conference contribution Nilotinib Vs Nilotinib Plus Pegylated Interferon a (Peg-IFN) Induction and Nilotinib or Peg-IFN Maintenance Therapy for Newly Diagnosed BCR-ABL1 Positive Chronic Myeloid Leukemia Patients in Chronic Phase (TIGER Study): The Addition of Peg-IFN Is Associated with Higher Rates of Deep Molecular Response (2019) Hochhaus A, Burchert A, Saussele S, Baerlocher GM, Brummendorf TH, Rosee PL, Heim D, et al. Conference contribution Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis (2019) Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP, Khanna D, et al. Journal article β6-integrin serves as a novel serum tumor marker for colorectal carcinoma (2019) Bengs S, Becker E, Busenhart P, Spalinger MR, Raselli T, Kasper S, Lang S, et al. Journal article, Original article SERUM KINETICS OF CARTILAGE BIOLOGICAL MARKERS IN RESPONSE TO IMMOBILIZATION AND PHYSICAL EXERCISE, AND THE POTENTIAL ROLE OF CGS IN THIS CONTEXT (2019) Liphardt AM, Mundermann A Conference contribution Ischemic stroke despite oral anticoagulant therapy in patients with AF: recurrence risk and optimal anticoagulation strategy (2019) Seiffge D, De Marchis GM, Koga M, Paciaroni M, Wilson D, Cappellari M, Macha K, et al. Conference contribution